Stock CRVO CERVOMED INC.
Add to a list
To use this feature you must be a member
Log inSign up

News CervoMed Inc.

Equities

CRVO

US15713L1098

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
20 USD 0.00% Intraday chart for CervoMed Inc. +7.24% +162.12%
11/06 CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies CI
29/05 JonesTrading Starts CervoMed With Buy Rating, $70 Price Target MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CervoMed Announces Addition to Russell 2000® and Russell 3000® Indexes
AQ
CervoMed : Corporate Presentation June 2024
PU
CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies
AQ
CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies
CI
JonesTrading Starts CervoMed With Buy Rating, $70 Price Target
MT
CervoMed Names William Elder CFO
MT
CervoMed to Appoint William Elder as Chief Financial Officer
AQ
CervoMed Inc. Announces Chief Financial Officer Changes
CI
Earnings Flash (CRVO) CERVOMED Posts Q1 Revenue $2.3M
MT
CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
AQ
CervoMed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CervoMed : Nominating and Corporate Governance Committee Charter
PU
CervoMed : Corporate Presentation April 2024
PU
Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating
MT
CervoMed : Corporate Presentation April 2024
PU
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
AQ
CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CervoMed to Participate in Upcoming Investor Conferences
AQ
CervoMed Prices $50 Million Equity Sale to Private Investors
MT
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRVO Stock
  4. News CervoMed Inc.